Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy.
about
Inhibition of phosphoinositide 3-kinase/Akt pathway decreases hypoxia inducible factor-1α expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cellsSo-Cheong-Ryong-Tang induces apoptosis through activation of the intrinsic and extrinsic apoptosis pathways, and inhibition of the PI3K/Akt signaling pathway in non-small-cell lung cancer A549 cells.Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival.Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway.ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing.Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape.The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells.Overexpression of CRKL correlates with malignant cell proliferation in breast cancer.Synergistic effects of erlotinib and everolimus on bronchial carcinoids and large-cell neuroendocrine carcinomas with activated EGFR/AKT/mTOR pathway.Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date.Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis.Expression of the mammalian target of rapamycin pathway markers in lung adenocarcinoma and squamous cell carcinoma.Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer.
P2860
Q28384554-71E50813-08CB-49F0-B7E7-8311872CA2DAQ35424594-8F1FF6C2-5C04-4F8D-A9D4-92C29754F2BCQ36772120-53BAE1EC-9B1E-4958-B851-4FBEB8698130Q37745860-9F69E6E6-0414-4ECA-BBD0-C189548DA440Q37853928-5E3C0555-5DC3-4CAD-8027-E677B94C9288Q38583728-7159163C-944D-4F1D-9C1B-10C346291FCDQ38922208-30B944E4-324F-4003-AF88-AE1077AC0027Q39127472-D98255F4-EC86-40BA-94A0-A7E91A996592Q39137614-2F1A9CD3-F0A4-4F81-BCA3-219E4822A51DQ39149858-4398CC48-3C4C-44F4-9FC1-7CBDA341118CQ39388106-91160C36-B3AA-4316-95F7-621742C47622Q49478004-E115D14A-C4B6-4808-B750-58F0BB48DE25Q51150179-8634785C-24BC-4BCE-9BB8-50C8473E1C7CQ53282153-1D2E825B-6C20-4CC8-AC89-00B17BB71AB3Q54533454-2A5A90AE-95B8-4B70-B1FD-4BE3D743C99AQ55105956-8A00ED93-2779-4876-8E9F-001039F63B40
P2860
Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Prognostic and predictive valu ...... ed with adjuvant chemotherapy.
@en
Prognostic and predictive valu ...... ed with adjuvant chemotherapy.
@nl
type
label
Prognostic and predictive valu ...... ed with adjuvant chemotherapy.
@en
Prognostic and predictive valu ...... ed with adjuvant chemotherapy.
@nl
prefLabel
Prognostic and predictive valu ...... ed with adjuvant chemotherapy.
@en
Prognostic and predictive valu ...... ed with adjuvant chemotherapy.
@nl
P2093
P2860
P1433
P1476
Prognostic and predictive valu ...... ted with adjuvant chemotherapy
@en
P2093
Ling-Xiong Wang
Shun-Chang Jiao
P2860
P2888
P304
P356
10.1007/S13277-010-0131-8
P50
P577
2010-11-18T00:00:00Z